RecruitingPhase 2NCT07279714
Fisetin in Mild Alzheimer's Disease
Fisetin Intervention Study in Mild Alzheimer's Disease
Sponsor
Sunnybrook Health Sciences Centre
Enrollment
5 participants
Start Date
Jan 27, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.
Eligibility
Min Age: 60 Years
Inclusion Criteria3
- Mild cognitive impairment due to Alzheimer's disease OR mild Alzheimer Dementia
- Moca score of 11 or higher
- Stable psychotropics and cognitive enhancing medications
Exclusion Criteria12
- Known hypersensitivity or allergy to fisetin
- Presence of any medical condition, or abnormal routine blood test, that the investigator believes would put the subject at risk or would preclude the patient from completing all aspects of the trial
- Unstable medical disorders
- Ongoing treatment for active infection with antibiotics/antifungals
- Ongoing treatment for cancer
- Active alcohol or substance use disorder
- Recent active bleeding
- Patients taking oral anticoagulants, anti-cancer, anti-seizure medications, or other medications that could have a significant interaction with fisetin
- Use within the last month of other senolytic supplements, antioxidant supplements, natural health products
- Other neurologic or neurodegenerative conditions impacting cognition
- Active Major Depressive Episode, active suicidal thoughts or psychosis
- Any thing that would preclude the ability to undergo an MRI scan
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERFisetin
Fisetin 20mg/kg/day
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07279714
Related Trials
rTMS for Apathy Clinical Trial
NCT055612051 location
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
NCT071696301 location
Cognitive Neurology Unit Clinical Registry
NCT059256211 location
Links Between Cognitive Deficits During Normal or Pathological Aging and Slow Waves Measured in EEG
NCT065014951 location
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
NCT070129931 location